Metastatic Breast Cancer Therapy Effectiveness Gauged By Immunicon Kits
This article was originally published in The Gray Sheet
Executive Summary
Veridex is rolling out Immunicon's circulating tumor cell selection and enumeration IVD systems to roughly 20 U.S. comprehensive cancer centers and clinical labs